Lindsted, Trine,Grandal, Michael Monrad,Melander, Eva Maria Carlsen,Fröhlich, Camilla,Pedersen, Mikkel Wandahl,Kragh, Michael,Lantto, Johan,Gad, Monika,Horak, Ivan David
申请号：
AU2018247916
公开号：
AU2018247916A1
申请日:
2018.04.05
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
This disclosure relates to combination therapies targeting two or all of PD-1, TIM-3, and LAG-3 using antibodies specific for these targets in patients who are in need of enhanced immunity. Also included in the disclosure are compositions useful in the therapies. The therapies are useful in treating diseases such as cancers.
